Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Guidelines for the implantation of defibrillators].

Literature DB >> 17103126

[Guidelines for the implantation of defibrillators].

W Jung¹, D Andresen, M Block, D Böcker, S H Hohnloser, K-H Kuck, J Sperzel.

Abstract

Mesh：

Year: 2006 PMID： 17103126 DOI： 10.1007/s00392-006-0475-7

Source DB: PubMed Journal: Clin Res Cardiol ISSN： 1861-0684 Impact factor: 5.460

× No keyword cloud information.

44 in total

1. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors: K H Kuck; R Cappato; J Siebels; R Rüppel
Journal: Circulation Date: 2000-08-15 Impact factor: 29.690

2. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis.

Authors: Rainer Schimpf; Urs Bauersfeld; Fiorenzo Gaita; Christian Wolpert
Journal: Heart Rhythm Date: 2005-04 Impact factor: 6.343

3. Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.

Authors: A P Hallstrom; H L Greene; D G Wyse; D Zipes; A E Epstein; M J Domanski; E B Schron
Journal: Am J Cardiol Date: 1995-03-01 Impact factor: 2.778

4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors:
Journal: N Engl J Med Date: 1997-11-27 Impact factor: 91.245

5. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors: S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal: Circulation Date: 2000-03-21 Impact factor: 29.690

6. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.

Authors: M J Domanski; S Sakseena; A E Epstein; A P Hallstrom; M A Brodsky; S Kim; S Lancaster; E Schron
Journal: J Am Coll Cardiol Date: 1999-10 Impact factor: 24.094

7. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.

Authors: James R Cook; Carlos Rizo-Patron; Anne B Curtis; Anne M Gillis; J Thomas Bigger; Steven P Kutalek; James Coromilas; Bradley I Hofer; Judy Powell; Alfred P Hallstrom
Journal: Am Heart J Date: 2002-05 Impact factor: 4.749

8. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).

Authors: J Siebels; K H Kuck
Journal: Am Heart J Date: 1994-04 Impact factor: 4.749

9. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors: Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal: Circulation Date: 2003-11-24 Impact factor: 29.690

10. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors: Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245

33 in total

Review 1. [Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].

Authors: T Sellmann; M Winterhalter; U Herold; P Kienbaum
Journal: Anaesthesist Date: 2010-06 Impact factor: 1.041

Review 2. Long-range silencing and position effects at telomeres and centromeres: parallels and differences.

Authors: S Perrod; S M Gasser
Journal: Cell Mol Life Sci Date: 2003-11 Impact factor: 9.261

3. [The "Recommendations for the structure of cardiac pacemaker and defibrillator therapy"--what can they achieve?: Implementation of the concept paper for HSM/ICD therapy].

Authors: K Rybak
Journal: Herzschrittmacherther Elektrophysiol Date: 2010-09

[Guidelines for the implantation of defibrillators].

1. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

2. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis.

3. Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.

4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

5. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

6. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.

7. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.

8. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).

9. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

10. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Review 1. [Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].

Review 2. Long-range silencing and position effects at telomeres and centromeres: parallels and differences.

3. [The "Recommendations for the structure of cardiac pacemaker and defibrillator therapy"--what can they achieve?: Implementation of the concept paper for HSM/ICD therapy].

4. [ICD therapy for primary prevention. The patient in the early post-infarct phase].

Review 5. [Electrophysiologic diagnosis and therapy].

6. [ICD therapy as secondary prevention].

7. [Home monitoring of an incessant VT in an ICD patient].

8. Delayed enhancement magnetic resonance imaging in isolated noncompaction of ventricular myocardium.

9. Persistent left superior vena cava as a cause for an unsuccessful ICD implant.

Review 10. [ICD lead defects: diagnosis and therapeutical options].